Executive record

Gregory W. Matz, CPA

Director at Dare Bioscience, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:gregory-w-matz-cpaVersion: public-0As of: 2026-09-28

Not yet claimed7 published Claims3 sources
  • Director

Key Claims

Biography

Mr. Matz is a retired Senior Vice President and Chief Financial Officer of The Cooper Companies, a publicly traded global medical device company. He previously held CFO roles at CooperVision and key management positions at Agilent Technologies and Hewlett Packard. He is a CPA and has earned NACD Directorship Certification and NACD/Carnegie Mellon University CERT Certification in Cybersecurity Oversight.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Board service

Boards

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. DARE DEF 14A director slate

    sec filing · Source published: Apr 24, 2025 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Audit, Nominating/Governance · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience reported in filings · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Apr 24, 2025 · Retrieved: Apr 28, 2026

    Supports 1 claim
    • Professional Role: Director at Dare Bioscience, Inc. · Claim reviewed: May 15, 2026

  3. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Dare Bioscience, Inc. · Claim reviewed: May 15, 2026